Peptide Checkpoint Inhibitors

Peptide-Based Immune Checkpoint Inhibitors

Peptide checkpoint inhibitors offer smaller, tumor-penetrating alternatives to antibodies like nivolumab. From macrocyclic PD-L1 blockers to peptide vaccines.